 Nicole Marjon
Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ovarian Neoplasms | 5 | 2024 | 586 | 0.890 |
Why?
| | Genetic Testing | 1 | 2023 | 482 | 0.640 |
Why?
| | Receptors, G-Protein-Coupled | 3 | 2014 | 233 | 0.490 |
Why?
| | Mammary Neoplasms, Animal | 1 | 2014 | 34 | 0.420 |
Why?
| | Carcinogenesis | 1 | 2014 | 229 | 0.370 |
Why?
| | Tumor Microenvironment | 3 | 2024 | 735 | 0.350 |
Why?
| | Cystadenocarcinoma, Serous | 2 | 2024 | 84 | 0.250 |
Why?
| | Tryptophan Oxygenase | 1 | 2024 | 33 | 0.210 |
Why?
| | Arrestins | 2 | 2016 | 14 | 0.190 |
Why?
| | Receptors, Formyl Peptide | 2 | 2016 | 17 | 0.190 |
Why?
| | Genetic Counseling | 1 | 2023 | 81 | 0.190 |
Why?
| | Germ-Line Mutation | 1 | 2023 | 175 | 0.180 |
Why?
| | Lung Neoplasms | 1 | 2014 | 2642 | 0.160 |
Why?
| | Frozen Sections | 1 | 2019 | 24 | 0.140 |
Why?
| | Sentinel Lymph Node Biopsy | 1 | 2019 | 118 | 0.140 |
Why?
| | Lymphatic Metastasis | 1 | 2019 | 334 | 0.130 |
Why?
| | Pilot Projects | 1 | 2023 | 1890 | 0.130 |
Why?
| | Endometrial Neoplasms | 1 | 2018 | 208 | 0.120 |
Why?
| | src-Family Kinases | 1 | 2016 | 93 | 0.110 |
Why?
| | CTLA-4 Antigen | 1 | 2015 | 104 | 0.110 |
Why?
| | Hyperplasia | 1 | 2014 | 174 | 0.100 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2015 | 193 | 0.100 |
Why?
| | Ovariectomy | 1 | 2014 | 162 | 0.100 |
Why?
| | Receptors, Estrogen | 2 | 2014 | 457 | 0.100 |
Why?
| | Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2015 | 132 | 0.100 |
Why?
| | Tamoxifen | 1 | 2014 | 217 | 0.100 |
Why?
| | Estrogen Receptor alpha | 1 | 2014 | 161 | 0.090 |
Why?
| | Prognosis | 2 | 2024 | 4293 | 0.090 |
Why?
| | Estrogens | 1 | 2014 | 380 | 0.090 |
Why?
| | Adaptor Protein Complex 2 | 1 | 2009 | 11 | 0.070 |
Why?
| | Growth | 1 | 2009 | 49 | 0.070 |
Why?
| | Mice, Transgenic | 1 | 2014 | 2185 | 0.070 |
Why?
| | Growth Disorders | 1 | 2009 | 86 | 0.070 |
Why?
| | Aged | 3 | 2024 | 25947 | 0.070 |
Why?
| | Malnutrition | 1 | 2009 | 86 | 0.070 |
Why?
| | Body Height | 1 | 2009 | 202 | 0.070 |
Why?
| | Retrospective Studies | 2 | 2023 | 17101 | 0.060 |
Why?
| | Female | 8 | 2024 | 78376 | 0.060 |
Why?
| | Cell Proliferation | 1 | 2014 | 2499 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2016 | 2609 | 0.060 |
Why?
| | Middle Aged | 3 | 2024 | 35928 | 0.060 |
Why?
| | Macrophages | 2 | 2024 | 1511 | 0.060 |
Why?
| | Apoptosis | 2 | 2016 | 2430 | 0.060 |
Why?
| | Atherosclerosis | 1 | 2009 | 409 | 0.050 |
Why?
| | Body Weight | 1 | 2009 | 978 | 0.050 |
Why?
| | BRCA2 Protein | 1 | 2024 | 67 | 0.050 |
Why?
| | Humans | 10 | 2024 | 144957 | 0.050 |
Why?
| | Polycomb Repressive Complex 1 | 1 | 2024 | 66 | 0.050 |
Why?
| | Antineoplastic Agents | 1 | 2015 | 2197 | 0.050 |
Why?
| | Neoplasm Grading | 1 | 2024 | 309 | 0.050 |
Why?
| | Adult | 3 | 2023 | 40506 | 0.050 |
Why?
| | Kynurenine | 1 | 2024 | 114 | 0.050 |
Why?
| | Animals | 5 | 2024 | 38109 | 0.050 |
Why?
| | Tryptophan | 1 | 2024 | 181 | 0.050 |
Why?
| | Blood Pressure | 1 | 2009 | 1769 | 0.040 |
Why?
| | B7-H1 Antigen | 1 | 2024 | 241 | 0.040 |
Why?
| | Protein Transport | 2 | 2016 | 441 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2024 | 826 | 0.040 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2024 | 531 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2024 | 780 | 0.040 |
Why?
| | Intraoperative Period | 1 | 2019 | 69 | 0.040 |
Why?
| | Pelvic Exenteration | 1 | 2018 | 12 | 0.040 |
Why?
| | Salpingo-oophorectomy | 1 | 2018 | 18 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2024 | 1462 | 0.030 |
Why?
| | Hysterectomy | 1 | 2018 | 138 | 0.030 |
Why?
| | Lymph Node Excision | 1 | 2018 | 173 | 0.030 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2018 | 421 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2018 | 769 | 0.030 |
Why?
| | Protein Binding | 2 | 2016 | 2276 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2024 | 3550 | 0.030 |
Why?
| | Gynecology | 1 | 2018 | 178 | 0.030 |
Why?
| | Mice | 3 | 2024 | 18365 | 0.030 |
Why?
| | Medical Oncology | 1 | 2018 | 332 | 0.030 |
Why?
| | Obesity | 1 | 2009 | 3082 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2016 | 341 | 0.030 |
Why?
| | Neoplasm Transplantation | 1 | 2015 | 252 | 0.030 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2015 | 223 | 0.030 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2015 | 194 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2018 | 1465 | 0.030 |
Why?
| | Guideline Adherence | 1 | 2018 | 589 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 983 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2015 | 919 | 0.020 |
Why?
| | T-Lymphocyte Subsets | 1 | 2015 | 415 | 0.020 |
Why?
| | Immunologic Memory | 1 | 2015 | 366 | 0.020 |
Why?
| | Cross-Sectional Studies | 2 | 2018 | 5872 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2015 | 1268 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2015 | 784 | 0.020 |
Why?
| | Phosphorylation | 1 | 2016 | 1733 | 0.020 |
Why?
| | Cell Movement | 1 | 2016 | 965 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2015 | 2032 | 0.020 |
Why?
| | Immunotherapy | 1 | 2015 | 657 | 0.020 |
Why?
| | Palliative Care | 1 | 2018 | 1008 | 0.020 |
Why?
| | U937 Cells | 1 | 2009 | 27 | 0.020 |
Why?
| | Nigeria | 1 | 2009 | 24 | 0.020 |
Why?
| | Mammary Arteries | 1 | 2009 | 8 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2009 | 151 | 0.020 |
Why?
| | World Health Organization | 1 | 2009 | 105 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2016 | 3125 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2009 | 299 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2016 | 4155 | 0.020 |
Why?
| | Endosomes | 1 | 2009 | 140 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2015 | 1524 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 418 | 0.020 |
Why?
| | Green Fluorescent Proteins | 1 | 2009 | 405 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2016 | 2832 | 0.020 |
Why?
| | Reference Values | 1 | 2009 | 798 | 0.020 |
Why?
| | Transfection | 1 | 2009 | 940 | 0.020 |
Why?
| | Blotting, Western | 1 | 2009 | 1187 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 8279 | 0.010 |
Why?
| | Vasodilation | 1 | 2009 | 523 | 0.010 |
Why?
| | Estradiol | 1 | 2009 | 533 | 0.010 |
Why?
| | Breast Feeding | 1 | 2009 | 448 | 0.010 |
Why?
| | Socioeconomic Factors | 1 | 2009 | 1327 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2015 | 5997 | 0.010 |
Why?
| | Risk Factors | 1 | 2018 | 10792 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2018 | 11695 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2009 | 2540 | 0.010 |
Why?
| | Signal Transduction | 1 | 2016 | 5233 | 0.010 |
Why?
| | Prevalence | 1 | 2009 | 2836 | 0.010 |
Why?
| | Body Mass Index | 1 | 2009 | 2438 | 0.010 |
Why?
| | Rats | 1 | 2009 | 5614 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2009 | 6434 | 0.010 |
Why?
| | Infant | 1 | 2009 | 10039 | 0.010 |
Why?
| | Child, Preschool | 1 | 2009 | 11799 | 0.010 |
Why?
| | Male | 2 | 2009 | 72406 | 0.010 |
Why?
|
|
Marjon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|